Squarepoint Ops LLC X Biotech Inc. Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.56 - $4.65 $67,362 - $87,987	18,922 New	18,922 $75,000
Q2 2022 Aug 15, 2022	BUY	$5.13 - $9.2 $57,399 - $102,938	11,189 New	11,189 $63,000
Q2 2020 Aug 14, 2020	SELL	$10.39 - $16.07 $118,601 - $183,439	-11,415 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$8.89 - $24.94 $227,655 - $638,663	-25,608 Reduced 69.17%	11,415 $121,000
Q4 2019 Feb 14, 2020	BUY	$8.33 - $19.95 $201,044 - $481,493	24,135 Added 187.27%	37,023 $691,000
Q3 2019 Nov 14, 2019	BUY	$6.86 - $10.46 $88,411 - $134,808	12,888 New	12,888 $135,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.